Report Detail

Pharma & Healthcare Global Anticancer Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4593424
  • |
  • 05 June, 2024
  • |
  • Global
  • |
  • 113 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Anticancer Drugs market size was valued at USD 87460 million in 2023 and is forecast to a readjusted size of USD 111580 million by 2030 with a CAGR of 3.5% during review period.
Anticancer drugs are medications used to treat cancer by targeting and killing cancer cells or inhibiting their growth.
The market for anticancer drugs is driven by the increasing incidence of cancer and the growing demand for effective and personalized cancer treatments. The development of targeted and immunotherapeutic drugs further boosts the market growth.
The Global Info Research report includes an overview of the development of the Anticancer Drugs industry chain, the market status of Lung Cancer (Cytotoxic Drugs (Alkylating Agents, and Antimetabolites), Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)), Breast Cancer (Cytotoxic Drugs (Alkylating Agents, and Antimetabolites), Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Anticancer Drugs.
Regionally, the report analyzes the Anticancer Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Anticancer Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Anticancer Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Anticancer Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (MT), revenue generated, and market share of different by Type (e.g., Cytotoxic Drugs (Alkylating Agents, and Antimetabolites), Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Anticancer Drugs market.
Regional Analysis: The report involves examining the Anticancer Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Anticancer Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Anticancer Drugs:
Company Analysis: Report covers individual Anticancer Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Anticancer Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Lung Cancer, Breast Cancer).
Technology Analysis: Report covers specific technologies relevant to Anticancer Drugs. It assesses the current state, advancements, and potential future developments in Anticancer Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Anticancer Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Anticancer Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
Hormonal Drugs
Market segment by Application
Lung Cancer
Breast Cancer
Leukemia
Colorectal Cancer
Other
Major players covered
F. Hoffmann-La Roche Ltd
Eli Lilly and Company
CELGENE CORPORATION
Novartis AG
Pfizer Inc
Amgen Inc
Bayer AG
AstraZeneca
Takeda Pharmaceutical Company Limited
Merck & Co.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anticancer Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Anticancer Drugs, with price, sales, revenue and global market share of Anticancer Drugs from 2019 to 2024.
Chapter 3, the Anticancer Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anticancer Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Anticancer Drugs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Anticancer Drugs.
Chapter 14 and 15, to describe Anticancer Drugs sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Anticancer Drugs
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Anticancer Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
    • 1.3.3 Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
    • 1.3.4 Hormonal Drugs
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Anticancer Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Lung Cancer
    • 1.4.3 Breast Cancer
    • 1.4.4 Leukemia
    • 1.4.5 Colorectal Cancer
    • 1.4.6 Other
  • 1.5 Global Anticancer Drugs Market Size & Forecast
    • 1.5.1 Global Anticancer Drugs Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Anticancer Drugs Sales Quantity (2019-2030)
    • 1.5.3 Global Anticancer Drugs Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 F. Hoffmann-La Roche Ltd
    • 2.1.1 F. Hoffmann-La Roche Ltd Details
    • 2.1.2 F. Hoffmann-La Roche Ltd Major Business
    • 2.1.3 F. Hoffmann-La Roche Ltd Anticancer Drugs Product and Services
    • 2.1.4 F. Hoffmann-La Roche Ltd Anticancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
  • 2.2 Eli Lilly and Company
    • 2.2.1 Eli Lilly and Company Details
    • 2.2.2 Eli Lilly and Company Major Business
    • 2.2.3 Eli Lilly and Company Anticancer Drugs Product and Services
    • 2.2.4 Eli Lilly and Company Anticancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Eli Lilly and Company Recent Developments/Updates
  • 2.3 CELGENE CORPORATION
    • 2.3.1 CELGENE CORPORATION Details
    • 2.3.2 CELGENE CORPORATION Major Business
    • 2.3.3 CELGENE CORPORATION Anticancer Drugs Product and Services
    • 2.3.4 CELGENE CORPORATION Anticancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 CELGENE CORPORATION Recent Developments/Updates
  • 2.4 Novartis AG
    • 2.4.1 Novartis AG Details
    • 2.4.2 Novartis AG Major Business
    • 2.4.3 Novartis AG Anticancer Drugs Product and Services
    • 2.4.4 Novartis AG Anticancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Novartis AG Recent Developments/Updates
  • 2.5 Pfizer Inc
    • 2.5.1 Pfizer Inc Details
    • 2.5.2 Pfizer Inc Major Business
    • 2.5.3 Pfizer Inc Anticancer Drugs Product and Services
    • 2.5.4 Pfizer Inc Anticancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Pfizer Inc Recent Developments/Updates
  • 2.6 Amgen Inc
    • 2.6.1 Amgen Inc Details
    • 2.6.2 Amgen Inc Major Business
    • 2.6.3 Amgen Inc Anticancer Drugs Product and Services
    • 2.6.4 Amgen Inc Anticancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Amgen Inc Recent Developments/Updates
  • 2.7 Bayer AG
    • 2.7.1 Bayer AG Details
    • 2.7.2 Bayer AG Major Business
    • 2.7.3 Bayer AG Anticancer Drugs Product and Services
    • 2.7.4 Bayer AG Anticancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Bayer AG Recent Developments/Updates
  • 2.8 AstraZeneca
    • 2.8.1 AstraZeneca Details
    • 2.8.2 AstraZeneca Major Business
    • 2.8.3 AstraZeneca Anticancer Drugs Product and Services
    • 2.8.4 AstraZeneca Anticancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 AstraZeneca Recent Developments/Updates
  • 2.9 Takeda Pharmaceutical Company Limited
    • 2.9.1 Takeda Pharmaceutical Company Limited Details
    • 2.9.2 Takeda Pharmaceutical Company Limited Major Business
    • 2.9.3 Takeda Pharmaceutical Company Limited Anticancer Drugs Product and Services
    • 2.9.4 Takeda Pharmaceutical Company Limited Anticancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
  • 2.10 Merck & Co.
    • 2.10.1 Merck & Co. Details
    • 2.10.2 Merck & Co. Major Business
    • 2.10.3 Merck & Co. Anticancer Drugs Product and Services
    • 2.10.4 Merck & Co. Anticancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Merck & Co. Recent Developments/Updates

3 Competitive Environment: Anticancer Drugs by Manufacturer

  • 3.1 Global Anticancer Drugs Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Anticancer Drugs Revenue by Manufacturer (2019-2024)
  • 3.3 Global Anticancer Drugs Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Anticancer Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Anticancer Drugs Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Anticancer Drugs Manufacturer Market Share in 2023
  • 3.5 Anticancer Drugs Market: Overall Company Footprint Analysis
    • 3.5.1 Anticancer Drugs Market: Region Footprint
    • 3.5.2 Anticancer Drugs Market: Company Product Type Footprint
    • 3.5.3 Anticancer Drugs Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Anticancer Drugs Market Size by Region
    • 4.1.1 Global Anticancer Drugs Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Anticancer Drugs Consumption Value by Region (2019-2030)
    • 4.1.3 Global Anticancer Drugs Average Price by Region (2019-2030)
  • 4.2 North America Anticancer Drugs Consumption Value (2019-2030)
  • 4.3 Europe Anticancer Drugs Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Anticancer Drugs Consumption Value (2019-2030)
  • 4.5 South America Anticancer Drugs Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Anticancer Drugs Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Anticancer Drugs Sales Quantity by Type (2019-2030)
  • 5.2 Global Anticancer Drugs Consumption Value by Type (2019-2030)
  • 5.3 Global Anticancer Drugs Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Anticancer Drugs Sales Quantity by Application (2019-2030)
  • 6.2 Global Anticancer Drugs Consumption Value by Application (2019-2030)
  • 6.3 Global Anticancer Drugs Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Anticancer Drugs Sales Quantity by Type (2019-2030)
  • 7.2 North America Anticancer Drugs Sales Quantity by Application (2019-2030)
  • 7.3 North America Anticancer Drugs Market Size by Country
    • 7.3.1 North America Anticancer Drugs Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Anticancer Drugs Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Anticancer Drugs Sales Quantity by Type (2019-2030)
  • 8.2 Europe Anticancer Drugs Sales Quantity by Application (2019-2030)
  • 8.3 Europe Anticancer Drugs Market Size by Country
    • 8.3.1 Europe Anticancer Drugs Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Anticancer Drugs Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Anticancer Drugs Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Anticancer Drugs Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Anticancer Drugs Market Size by Region
    • 9.3.1 Asia-Pacific Anticancer Drugs Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Anticancer Drugs Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Anticancer Drugs Sales Quantity by Type (2019-2030)
  • 10.2 South America Anticancer Drugs Sales Quantity by Application (2019-2030)
  • 10.3 South America Anticancer Drugs Market Size by Country
    • 10.3.1 South America Anticancer Drugs Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Anticancer Drugs Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Anticancer Drugs Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Anticancer Drugs Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Anticancer Drugs Market Size by Country
    • 11.3.1 Middle East & Africa Anticancer Drugs Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Anticancer Drugs Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Anticancer Drugs Market Drivers
  • 12.2 Anticancer Drugs Market Restraints
  • 12.3 Anticancer Drugs Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Anticancer Drugs and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Anticancer Drugs
  • 13.3 Anticancer Drugs Production Process
  • 13.4 Anticancer Drugs Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Anticancer Drugs Typical Distributors
  • 14.3 Anticancer Drugs Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Anticancer Drugs. Industry analysis & Market Report on Anticancer Drugs is a syndicated market report, published as Global Anticancer Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Anticancer Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,738.76
    4,108.14
    5,477.52
    3,239.88
    4,859.82
    6,479.76
    549,387.60
    824,081.40
    1,098,775.20
    290,232.00
    435,348.00
    580,464.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report